McDaid HM - Search Results

1

Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants.

McDaid HM, Lopez-Barcons L, Grossman A, Lia M, Keller S, Pérez-Soler R, Horwitz SB. McDaid HM, et al. Cancer Res. 2005 Apr 1;65(7):2854-60. doi: 10.1158/0008-5472.CAN-04-4391. Cancer Res. 2005. PMID: 15805287

2

Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice.

Huang GS, Lopez-Barcons L, Freeze BS, Smith AB 3rd, Goldberg GL, Horwitz SB, McDaid HM. Huang GS, et al. Among authors: mcdaid hm. Clin Cancer Res. 2006 Jan 1;12(1):298-304. doi: 10.1158/1078-0432.CCR-05-0229. Clin Cancer Res. 2006. PMID: 16397055 Free PMC article.

3

Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression.

Legrier ME, Yang CP, Yan HG, Lopez-Barcons L, Keller SM, Pérez-Soler R, Horwitz SB, McDaid HM. Legrier ME, et al. Among authors: mcdaid hm. Cancer Res. 2007 Dec 1;67(23):11300-8. doi: 10.1158/0008-5472.CAN-07-0702. Cancer Res. 2007. PMID: 18056456

4

Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.

McDaid HM, Horwitz SB. McDaid HM, et al. Mol Pharmacol. 2001 Aug;60(2):290-301. doi: 10.1124/mol.60.2.290. Mol Pharmacol. 2001. PMID: 11455016 Free PMC article.

5

Mechanisms of Taxol resistance related to microtubules.

Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Orr GA, et al. Oncogene. 2003 Oct 20;22(47):7280-95. doi: 10.1038/sj.onc.1206934. Oncogene. 2003. PMID: 14576838 Free PMC article. Review.

6

Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors.

Mani S, McDaid H, Hamilton A, Hochster H, Cohen MB, Khabelle D, Griffin T, Lebwohl DE, Liebes L, Muggia F, Horwitz SB. Mani S, et al. Clin Cancer Res. 2004 Feb 15;10(4):1289-98. doi: 10.1158/1078-0432.ccr-0919-03. Clin Cancer Res. 2004. PMID: 14977827 Clinical Trial.

7

The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical development.

Goel S, Cohen M, Cömezoglu SN, Perrin L, André F, Jayabalan D, Iacono L, Comprelli A, Ly VT, Zhang D, Xu C, Humphreys WG, McDaid H, Goldberg G, Horwitz SB, Mani S. Goel S, et al. Clin Cancer Res. 2008 May 1;14(9):2701-9. doi: 10.1158/1078-0432.CCR-07-4151. Clin Cancer Res. 2008. PMID: 18451235 Clinical Trial.

8

Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study.

McDaid HM, Mani S, Shen HJ, Muggia F, Sonnichsen D, Horwitz SB. McDaid HM, et al. Clin Cancer Res. 2002 Jul;8(7):2035-43. Clin Cancer Res. 2002. PMID: 12114401 Clinical Trial.

9

Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence.

Chao SK, Horwitz SB, McDaid HM. Chao SK, et al. Among authors: mcdaid hm. Oncotarget. 2011 Jan-Feb;2(1-2):89-98. doi: 10.18632/oncotarget.221. Oncotarget. 2011. PMID: 21399233 Free PMC article.

10

High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer.

Wang Y, Sparano JA, Fineberg S, Stead L, Sunkara J, Horwitz SB, McDaid HM. Wang Y, et al. Among authors: mcdaid hm. Clin Breast Cancer. 2013 Apr;13(2):103-8. doi: 10.1016/j.clbc.2012.11.003. Epub 2012 Dec 6. Clin Breast Cancer. 2013. PMID: 23218766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters